Paper40733014
Calcium Electrochemotherapy and Challenges in Combined Treatment with Dendritic Cell Vaccination.
Radzevičiūtė-Valčiukė E and 11 others. Pharmaceutics, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Calcium Electrochemotherapy and Challenges in Combined Treatment with Dendritic Cell Vaccination. Papers, record 40733014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40733014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Calcium Electrochemotherapy and Challenges in Combined Treatment with Dendritic Cell Vaccination.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| S-PD-24-124 | Lietuvos Mokslo Taryba | PubMed |
Source PubMed
References103
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28947140 | Co-delivery of tumor-derived exosomes with alpha-galactosylceramide on dendritic cell-based immunotherapy for glioblastoma. | Cancer Lett | 2017 | https://conductscience.org/library/papers/28947140 | PubMed |
| 2 | 16919266 | Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors. | Exp Mol Pathol | 2007 | https://conductscience.org/library/papers/16919266 | PubMed |
| 3 | 29178483 | Electrochemotherapy of unresectable cutaneous tumours with reduced dosages of intravenous bleomycin: analysis of 57 patients from the International Network for Sharing Practices of Electrochemotherapy registry. | J Eur Acad Dermatol Venereol | 2018 | https://conductscience.org/library/papers/29178483 | PubMed |
| 4 | 19786984 | Cyclophosphamide and cancer: golden anniversary. | Nat Rev Clin Oncol | 2009 | https://conductscience.org/library/papers/19786984 | PubMed |
| 5 | 26084029 | GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c(+)MHCII(+) Macrophages and Dendritic Cells. | Immunity | 2015 | https://conductscience.org/library/papers/26084029 | PubMed |
| 6 | 34300902 | Electrochemotherapy and Other Clinical Applications of Electroporation for the Targeted Therapy of Metastatic Melanoma. | Materials (Basel) | 2021 | https://conductscience.org/library/papers/34300902 | PubMed |
| 7 | 17613255 | Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. | Immunity | 2007 | https://conductscience.org/library/papers/17613255 | PubMed |
| 8 | 34631558 | Recent Advances in Experimental Dendritic Cell Vaccines for Cancer. | Front Oncol | 2021 | https://conductscience.org/library/papers/34631558 | PubMed |
| 9 | 36303448 | Guidelines for mouse and human DC generation. | Eur J Immunol | 2023 | https://conductscience.org/library/papers/36303448 | PubMed |
| 10 | 27294607 | Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis. | Cancer Immunol Immunother | 2016 | https://conductscience.org/library/papers/27294607 | PubMed |
| 11 | 9849482 | Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. | Eur J Cancer | 1998 | https://conductscience.org/library/papers/9849482 | PubMed |
| 12 | 11198480 | In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity. | Melanoma Res | 2000 | https://conductscience.org/library/papers/11198480 | PubMed |
| 13 | 31646087 | Trial watch: dendritic cell vaccination for cancer immunotherapy. | Oncoimmunology | 2019 | https://conductscience.org/library/papers/31646087 | PubMed |
| 14 | 9521319 | Dendritic cells and the control of immunity. | Nature | 1998 | https://conductscience.org/library/papers/9521319 | PubMed |
| 15 | 25083316 | Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells. | Oncoimmunology | 2014 | https://conductscience.org/library/papers/25083316 | PubMed |
| 16 | 37257227 | Advances in dendritic cell vaccination therapy of cancer. | Biomed Pharmacother | 2023 | https://conductscience.org/library/papers/37257227 | PubMed |
| 17 | 37304301 | The effectiveness of calcium electroporation combined with gene electrotransfer of a plasmid encoding IL-12 is tumor type-dependent. | Front Immunol | 2023 | https://conductscience.org/library/papers/37304301 | PubMed |
| 18 | 33244152 | The effect of calcium electroporation on viability, phenotype and function of melanoma conditioned macrophages. | Sci Rep | 2020 | https://conductscience.org/library/papers/33244152 | PubMed |
| 19 | 35458673 | Electroporation and Electrochemotherapy in Gynecological and Breast Cancer Treatment. | Molecules | 2022 | https://conductscience.org/library/papers/35458673 | PubMed |
| 20 | 2544306 | Determination of subcutaneous tumor size in athymic (nude) mice. | Cancer Chemother Pharmacol | 1989 | https://conductscience.org/library/papers/2544306 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40733014
GET https://conductscience.org/api/papers/v1/40733014/references?page=2